1 |
Varma, R., Varma, R., Allen, W., Wardi, A., 1975. Human umbilical cord hyaluronate neutral sugar content and carbohydrateprotein linkage studies. Biochimica et Biophysica Acta (BBA)-General Subjects 399, 139-144.
DOI
|
2 |
West, D., Hampson, I., Arnold, F., Kumar, S., 1985. Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-1326.
DOI
|
3 |
Wieland, J., Houchinray, T., Shea, L., 2007. Non-viral vector delivery from PEG-hyaluronic acid hydrogels. Journal of Controlled Release 120, 233-241.
DOI
|
4 |
Wilson, A., Zhou, W., Champion, H., Alber, S., Tang, Z., Kennel, S., Watkins, S., Huang, L., Pitt, B., Li, S., 2005. Targeted delivery of oligodeoxynucleotides to mouse lung endothelial cells in vitro and in vivo. Molecular Therapy 12, 510-518.
DOI
|
5 |
Xie, Y., Aillon, K.L., Cai, S., Christian, J.M, Davies NM, Berkland CJ, Forrest ML. 2010. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International Journal of Pharmaceutics 392, 156-163.
DOI
|
6 |
Xu, P., Quick, G.K., Yeo, Y., 2009. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials 30, 5834-5843.
DOI
|
7 |
Yenice, I., Mocan, M., Palaska, E., Bochot, A., Bilensoy, E., Vural, I., Irkec, M., Atillahincal, A., 2008. Hyaluronic acid coated poly--caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Experimental Eye Research 87, 162-167.
DOI
|
8 |
Sun, X., Ma, P., Cao, X., Ning, L., Tian, Y., Ren, C., 2009. Positive hyaluronan/PEI/DNA complexes as a target-specific intracellular delivery to malignant breast cancer. Drug Delivery 16, 357-362.
DOI
|
9 |
Rydell, N., Balazs, E., 1971. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clinical Orthopaedics and Related Research 80, 25.
DOI
|
10 |
Saraf, A., Hacker, M., Sitharaman, B., Grande-Allen, K., Barry, M., Mikos, A., 2008. Synthesis and conformational evaluation of a novel gene delivery vector for human mesenchymal stem cells. Biomacromolecules 9, 818-827.
DOI
|
11 |
Schiffelers, R., Ansari, A., Xu, J., Zhou, Q., Tang, Q., Storm, G., Molema, G., Lu, P., Scaria, P., Woodle, M., 2004. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic acids research 32, e149.
DOI
|
12 |
Segura, T., 2005. DNA delivery from hyaluronic acid-collagen hydrogels via a substrate-mediated approach. Biomaterials 26, 1575-1584.
DOI
|
13 |
Shim, W., Yoo, J., Bae, Y., Lee, D., 2005. Novel injectable pH and temperature sensitive block copolymer hydrogel. Biomacromolecules 6, 2930-2934.
DOI
|
14 |
Shu, X., Liu, Y., Luo, Y., Roberts, M., Prestwich, G., 2002. Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules 3, 1304-1311.
DOI
|
15 |
Singh, M., Briones, M., O'Hagan, D., 2001. A novel bioadhesive intranasal delivery system for inactivated influenza vaccines. Journal of Controlled Release 70, 267-276.
DOI
|
16 |
Sintzel, M., Bernatchez, S., Tabatabay, C., Gurny, R., 1996. Biomaterials in ophthalmic drug delivery. European journal of pharmaceutics and biopharmaceutics 42, 358-374.
|
17 |
Morimoto, K., Yamaguchi, H., Iwakura, Y., Morisaka, K., Ohashi Y., Nakai, Y., 1991. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. Pharmaceutical research 8, 471-474.
DOI
|
18 |
Luo, Y., Bernshaw, N., Lu, Z., Kopecek, J., Prestwich, G., 2002. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates. Pharmaceutical research 19, 396-402.
DOI
|
19 |
Lin, Q.-K., Ren, K.-F., Ji, J., 2009. Hyaluronic acid and chitosan-DNA complex multilayered thin film as surface-mediated nonviral gene delivery system. Colloids and Surfaces B: Biointerfaces 74, 298-303.
DOI
|
20 |
Ludwig, A., 2005. The use of mucoadhesive polymers in ocular drug delivery. Advanced drug delivery reviews 57, 1595-1639.
DOI
|
21 |
Luo, Y., Kirker, K., Prestwich, G., 2000. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. Journal of Controlled Release 69, 169-184.
DOI
|
22 |
Lutolf, M., Lauer-Fields, J., Schmoekel, H., Metters, A., Weber, F., Fields, G., Hubbell, J., 2003. Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: engineering cell-invasion characteristics. Proceedings of the National Academy of Sciences of the United States of America 100, 5413.
DOI
|
23 |
Maeda, H., Seymour, L., Miyamoto, Y., 1992. Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo. Bioconjugate chemistry 3, 351-362.
DOI
|
24 |
Marshall, K., 2000. Intra-articular hyaluronan therapy. Current opinion in rheumatology 12, 468.
DOI
|
25 |
Matsubara, Y., Katoh, S., Taniguchi, H., Oka, M., Kadota, J., Kohno, S., 2000. Expression of CD44 Variants in Lung Cancer and Its Relationship to Hyaluronan Binding. The Journal of International Medical Research 28, 78-90.
DOI
ScienceOn
|
26 |
Mok, H., Park, J., Park, T., 2007. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition. Bioconjugate Chem 18, 1483-1489.
DOI
|
27 |
Illum, L., Farraj, N., Fisher, A., Gill, I., Miglietta, M., Benedetti, L., 1994. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. Journal of Controlled Release 29, 133-141.
DOI
|
28 |
Kumar, A., Sahoo, B., Montpetit, A., Behera, S., Lockey, R., Mohapatra, S., 2007. Development of hyaluronic acid-Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides. Nanomedicine: Nanotechnology, Biology and Medicine 3, 132-137.
DOI
|
29 |
Huh, Y., Cho, H., Yoon, I., Choi, M., Kim, J., Oh, E., Chung, S., Shim, C., Kim, D., 2010. Preparation and evaluation of spraydried hyaluronic acid microspheres for intranasal delivery of fexofenadine hydrochloride. European Journal of Pharmaceutical Sciences.
|
30 |
Hume, L., Lee, H., Benedetti, L., Sanzgiri, Y., Topp, E., Stella, V., 1994. Ocular sustained delivery of prednisolone using hyaluronic acid benzyl ester films. International Journal of Pharmaceutics 111, 295-298.
DOI
|
31 |
Ito, T., Iidatanaka, N., Niidome, T., Kawano, T., Kubo, K., Yoshikawa, K., Sato, T., Yang, Z., Koyama, Y., 2006. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: Protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. Journal of Controlled Release 112, 382-388.
DOI
|
32 |
Ito, T., Yoshihara, C., Hamada, K., Koyama, Y., 2010. DNA/polyethyleneimine/
hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials 31, 2912-2918.
DOI
|
33 |
Jeong, B., Bae, Y., Kim, S., 2000. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. Journal of Controlled Release 63, 155-163.
DOI
ScienceOn
|
34 |
Jeong, B., Lee, K., Gutowska, A., An, Y., 2002. % Thermogelling Biodegradable Copolymer Aqueous Solutions for Injectable Protein Delivery and Tissue Engineering. Biomacromolecules 3, 865-868.
DOI
|
35 |
Laurent, T., 1998. The chemistry, biology and medical applications of hyaluronan and its derivatives: Portland Pr.
|
36 |
Yokota, A., Ishii, G., Sugaya, Y., Nishimura, M., Saito, Y., Harigaya, K., 1999. Potential use of serum CD44 as an indicator of tumour progression in acute leukemia. Hematological Oncology 17, 161-168.
DOI
|
37 |
Yun, Y., 2004. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25, 147-157.
DOI
|
38 |
Upadhyay, K.K., Bhatt, A.N, Mishra, A.K., Dwarakanath, B.S., Jain, S., Schatz, C., Le Meins, J.-F., Farooque, A., Chandraiah, G., Jain, A.K., 2010. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly( -benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials 31, 2882-2892.
DOI
|
39 |
Kuo, J., Swann, D., Prestwich, G., 1991. Chemical modification of hyaluronic acid by carbodiimides. Bioconjugate Chemistry 2, 232-241.
DOI
|
40 |
Kyyronen, K., Hume, L., Benedetti, L., Urtti, A., Topp, E., Stella., V., 1992. Methylprednisolone esters of hyaluronic acid in ophthalmic drug delivery: in vitro and in vivo release studies. International Journal of Pharmaceutics 80, 161-169.
DOI
|
41 |
Le Bourlais, C., Acar, L., Zia, H., Sado, P., Needham, T., Leverge, R., 1998. Ophthalmic drug delivery systems--recent advances. Progress in retinal and eye research 17, 33-58.
DOI
|
42 |
Lee, B., West, B., McLemore, R., Pauken, C., Vernon, B., 2006. Insitu injectable physically and chemically gelling NIPAAmbased copolymer system for embolization. Biomacromolecules 7, 2059-2064.
DOI
|
43 |
Lee, E., Kwon, M., Na, K., Bae, J., 2007a. Protein release behavior from porous microparticle with lysozyme/hyaluronate ionic complex. Colloids and Surfaces B: Biointerfaces 55, 125-130.
DOI
|
44 |
Lee, F., Chung, J., Kurisawa, M., 2009. An injectable hyaluronic acid-tyramine hydrogel system for protein delivery. Journal of Controlled Release 134, 186-193.
DOI
|
45 |
Lee, H., Mok, H., Lee, S., Oh, Y., Park, T., 2007b. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. Journal of Controlled Release 119, 245-252.
DOI
|
46 |
Lim, S., Martin, G., Berry, D., Brown, M., 2000. Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. Journal of Controlled Release 66, 281-292.
DOI
|
47 |
Jiang, G., Park, K., Kim, J., Kim, K., Hahn, S., 2009. Target Specific Intracellular Delivery of siRNA/PEI- HA Complex by Receptor Mediated Endocytosis. Molecular Pharmaceutics 6, 727-737.
DOI
|
48 |
Bourguignon, L., Zhu, H., Shao, L., Chen, Y., 2000. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. Journal of Biological Chemistry 275, 1829.
DOI
|
49 |
Brown, M., Jones, S., 2005. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin. Journal of the European Academy of Dermatology and Venereology 19, 308-318.
DOI
|
50 |
Bucolo, C., Mangiafico, P., 1999. Pharmacological profile of a new topical pilocarpine formulation. Journal of Ocular Pharmacology and Therapeutics 15, 567-573.
DOI
|
51 |
Gurny, R., Ryser, J., Tabatabay, C., Martenet, M., Edman, P., Camber, O., 1990. Precorneal residence time in humans of sodium hyaluronate as measured by gamma scintigraphy. Graefe's archive for clinical and experimental ophthalmology 228, 510-512.
DOI
|
52 |
Hahn, S., Jelacic, S., Maier, R., Stayton, P., Hoffman, A., 2004. Anti-inflammatory drug delivery from hyaluronic acid hydrogels. Journal of Biomaterials Science, Polymer Edition 15, 1111-1119.
DOI
|
53 |
Hahn, S., Oh, E., Miyamoto, H., Shimobouji, T., 2006. Sustained release formulation of erythropoietin using hyaluronic acid hydrogels crosslinked by Michael addition. International Journal of Pharmaceutics 322, 44-51.
DOI
|
54 |
Han, S.-E., Kang, H., Shim, G.Y., Kim S.J., Choi, H.-G., Kim, J., Hahn, S.K., Oh, Y.-K., 2009. Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides. Journal of Drug Targeting 17, 123-132.
DOI
|
55 |
Herbert, P., Murphy, K., Johnson, O., Dong, N., Jaworowicz, W., Tracy, M., Cleland, J., Putney, S., 1998. A large-scale process to produce microencapsulated proteins. Pharmaceutical research 15, 357-361.
DOI
|
56 |
Hirakura, T., Yasugi, K., Nemoto, T., Sato, M., Shimoboji, T., Aso, Y., Morimoto, N., Akiyoshi, K., 2009. Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: New system for sustained delivery of protein with a chaperone-like function. Journal of Controlled Release.
|
57 |
Hornof, M., de la Fuente, M., Hallikainen, M., Tammi, R.H., Urtti, A., 2008. Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells. The journal of gene medicine 10, 70-80.
DOI
|
58 |
de la Fuente M., Seijo, B., Alonso, M.J., 2008b. Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy. Investigative Ophthalmology & Visual Science 49, 2016-2024.
DOI
|
59 |
Horvat, S., Feher, A., Wolburg, H., Sipos, P., Veszelka, S., Toth, A., Kis, L., Kurunczi, A., Balogh, G., Kurti, L., 2009. Sodium hyaluronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. European journal of pharmaceutics and biopharmaceutics 72, 252-259.
DOI
|
60 |
de la Fuente M., Seijo, B., Alonso, M., 2008a. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules. Macromolecular bioscience 8, 441-450.
DOI
|
61 |
Dollo, G., Malinovsky, J., Peron, A., Chevanne, F., Pinaud, M., Verge, R., Corre, P., 2004. Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits. International Journal of Pharmaceutics 272, 109-119.
DOI
|
62 |
Edelstein, M., Abedi, M., Wixon, J., Edelstein, R., 2004. Gene therapy clinical trials worldwide 1989-2004-an overview. The journal of gene medicine 6, 597-602.
DOI
|
63 |
Elbert, D., Pratt, A., Lutolf, M., Halstenberg, S., Hubbell, J., 2001. Protein delivery from materials formed by self-selective conjugate addition reactions. Journal of Controlled Release 76, 11-25.
DOI
|
64 |
Eliaz, R., Szoka, Jr, F., 2001. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer research 61, 2592.
|
65 |
Esposito, E., Menegatti, E., Cortesi, R., 2005. Hyaluronan-based microspheres as tools for drug delivery: a comparative study. International Journal of Pharmaceutics 288, 35-49.
DOI
|
66 |
Cascone, M., Sim, B., 1995. Blends of synthetic and natural polymers as drug delivery systems for growth hormone. Biomaterials 16, 569-574.
DOI
|
67 |
Fischer, D., Li, Y., Ahlemeyer, B., Krieglstein, J., Kissel, T., 2003. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24, 1121-1131.
DOI
|
68 |
Goldman, C., Soroceanu, L., Smith, N., Gillespie, G., Shaw, W., Burgess, S., Bilbao, G., Curiel, D., 1997. In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer. Nature biotechnology 15, 462-466.
DOI
|
69 |
Camber, O., Edman, P., Gurny, R., 1987. Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits. Current eye research 6, 779-784.
DOI
|
70 |
Catterall, J., Jones, L., Turner, G., 1999. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clinical and Experimental Metastasis 17, 583-591.
DOI
|
71 |
Cho, K., Chung, T., Kim, B., Kim, M., Lee, J., Wee, W., Cho, C., 2003. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. International Journal of Pharmaceutics 260, 83-91.
DOI
|
72 |
Choi, K.Y., Chung, H., Min, K.H., Yoon, H.Y, Kim, K., Park, J.H., Kwon, I.C., Jeong, S.Y., 2010. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 31, 106-114.
DOI
|
73 |
Chono, S., Li, S., Conwell, C., Huang, L., 2008. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. Journal of Controlled Release 131, 64-69.
DOI
|
74 |
Chun, K.W., Lee, J.B., Kim, S.H., Park, T.G., 2005. Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 26, 3319-3326.
DOI
|
75 |
Auzenne, E., Ghosh, S., Khodadadian, M., Rivera, B., Farquhar, D., Price, R., Ravoori, M., Kundra, V., Freedman, R., Klostergaard, J., 2007. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44 (+) human ovarian carcinoma xenografts. Neoplasia (New York, NY) 9, 479.
DOI
|
76 |
Coradini, D., Pellizzaro, C., Miglierini, G., Daidone, M., Perbellini, A., 1999. Hyaluronic acid as drug delivery for sodium butyrate: improvement of the anti-proliferative activity on a breast-cancer cell line. International Journal of Cancer 81, 411-416.
DOI
|
77 |
Culty, M., Shizari, M., Thompson, E., Underhill, C., 1994. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. Journal of cellular physiology 160, 275-286.
DOI
|
78 |
Akima, K., Ito, H., Iwata, Y., Matsuo, K., Watari, N., Yanagi, M., Hagi, H., Oshima, K., Yagita, A., Atomi, Y., 1996. Evaluation of antitumor activities of hyaluronate binding antitumor drugs: synthesis, characterization and antitumor activity. Journal of Drug Targeting 4, 1-8.
DOI
|
79 |
Balazs, E., Denlinger, J., 1993. Viscosupplementation: a new concept in the treatment of osteoarthritis. Journal of rheumatology Supplement 20, 3-9.
|
80 |
Balazs, E., Leshchiner, A., 1987. Cross-linked gels of hyaluronic acid and products containing such gels. In: Google Patents.
|
81 |
Barbault-Foucher, S., Gref, R., Russo, P., Guechot, J., Bochot, A., 2002. Design of poly--caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. Journal of Controlled Release 83, 365-375.
DOI
|
82 |
Bernatchez, S.F., 1993. Ophthalmology.
|
83 |
Bothner, H., Wik, O., 1987. Rheology of hyaluronate. Acta Oto-Laryngologica 104, 25-30.
|
84 |
Tammi, R., Ripellino, J., Margolis, R., Tammi, M., 1988. Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe. Journal of Investigative Dermatology 90, 412-414.
DOI
|
85 |
Surace, C., Arpicco, S., Dufay -Wojcicki, A., Marsaud, V., Bouclier, C., Clay, D., Cattel, L., Renoir, J., Fattal, E., 2009. Lipoplexes targeting the CD44 hyaluronic acid receptor for efficient transfection of breast cancer cells. Molecular Pharmaceutics 6, 1062-1073.
DOI
|
86 |
Surendrakumar, K., Martyn, G., Hodgers, E., Jansen, M., Blair, J., 2003. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. Journal of Controlled Release 91, 385-394.
DOI
|
87 |
Takei, Y., Maruyama, A., Ferdous, A., Nishimura, Y., Kawano, S., Ikejima, K., Okumura, S., Asayama, S., Nogawa, M., Hashimoto, M., 2004. Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronanglycocalyx. The FASAB Journal 18: 699-701.
DOI
|
88 |
Tracy, M., 1998. Development and scale-up of a microsphere protein delivery system. Biotechnology progress 14, 108-115.
DOI
|
89 |
Turker, S., Onur, E., Ozer, Y., 2004. Nasal route and drug delivery systems. Pharmacy World & Science 26, 137-142.
DOI
|
90 |
Ugwoke, M., Agu, R., Verbeke, N., Kinget, R., 2005. Nasal mucoadhesive drug delivery: Background, applications, trends and future perspectives. Advanced drug delivery reviews 57, 1640-1665.
DOI
|
91 |
Prisell, P., Camber, O., Hiselius, J., Norstedt, G., 1992. Evaluation of hyaluronan as a vehicle for peptide growth factors. International Journal of Pharmaceutics 85, 51-56.
DOI
|
92 |
Ohri, R., Hahn, S., Hoffman, A., Stayton, P., Giachelli, C., 2004. Hyaluronic acid grafting mitigates calcification of glutaraldehyde-fixed bovine pericardium. Journal of Biomedical Materials Research Part A 70, 328-334.
|
93 |
Moriyama, K., Ooya, T., Yui, N., 1999. Hyaluronic acid grafted with poly (ethylene glycol) as a novel peptide formulation. Journal of Controlled Release 59, 77-86.
DOI
|
94 |
Necas, J., Bartosikova, L., Brauner, P., Kolar, J., 2008. Hyaluronic acid (hyaluronan): a review. Veterinarni Medicina 53, 397-411.
|
95 |
Oh, E., Park, K., Kim, K., Kim, J., Yang, J., Kong, J., Lee, M., Hoffman, A., Hahn, S., 2010. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. Journal of Controlled Release 141, 2-12.
DOI
|
96 |
Park, J., Chakrabarti, B., 1978. Conformational transition of hyaluronic acid carboxylic group participation and thermal effect. Biochimica et Biophysica Acta (BBA)-General Subjects 541, 263-269.
DOI
|
97 |
Peer, D., Margalit, R., 2004. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. International Journal of Cancer 108, 780-789.
DOI
|
98 |
Prestwich, G., Marecak, D., Marecek, J., Vercruysse, K., Ziebell, M., 1998. Controlled chemical modification of hyaluronic acid: synthesis, applications, and biodegradation of hydrazide derivatives. Journal of Controlled Release 53, 93-103.
DOI
|
99 |
Price, R., Berry, M., Navsaria, H., 2007. Hyaluronic acid: the scientific and clinical evidence. Journal of Plastic, Reconstructive & Aesthetic Surgery 60, 1110-1119.
DOI
|
100 |
Jiang, H., Wang, Y., Huang, Q., Li, Y., Xu, C., Zhu, K., Chen, W., 2005. Biodegradable hyaluronic acid/N-carboxyethyl chitosan/protein ternary complexes as implantable carriers for controlled protein release. Macromolecular bioscience 5, 1226-1233.
DOI
|
101 |
Johnson, O., Cleland, J., Lee, H., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A., Putney, S., 1996. A month-long effect from a single injection of microencapsulated human growth hormone. Nature Medicine 2, 795-799.
DOI
|
102 |
Kim, A., 2005. Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan film. Biomaterials 26, 1585-1593.
DOI
|
103 |
Kim, A., Checkla, D., Dehazya, P., Chen, W., 2003. Characterization of DNA-hyaluronan matrix for sustained gene transfer. Journal of Controlled Release 90, 81-95.
DOI
|
104 |
Kim, E.-J., Shim, G., Kim, K., Kwon, I.C., Oh, Y.-K., Shim, C.-K., 2009. Hyaluronic acid complexed to biodegradable poly Larginine for targeted delivery of siRNAs. The journal of gene medicine 11, 791-803.
DOI
|
105 |
Kim, M., Park, T., 2002. Temperature-responsive and degradable hyaluronic acid/Pluronic composite hydrogels for controlled release of human growth hormone. Journal of Controlled Release 80, 69-77.
DOI
|
106 |
Kim, S., Hahn, S., Kim, M., Kim, D., Lee, Y., 2005. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles. Journal of Controlled Release 104, 323-335.
DOI
|
107 |
Kobayashi, Y., Okamoto, A., Nishinari, K., 1994. Viscoelasticity of hyaluronic acid with different molecular weights. Biorheology 31, 235-244.
DOI
|